|
|
|
Insider
Information: |
More Robert J |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
14 |
|
Direct
Shares |
341,069 |
|
Indirect Shares
|
7,074,016 |
|
|
Direct
Value |
$569,888 |
|
|
Indirect Value
|
$2,996,433 |
|
|
Total
Shares |
7,415,085 |
|
|
Total
Value |
$3,566,321 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
44.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-12 |
8,000 |
Premium* |
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-04 |
3,333 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2007-06-06 |
73,575 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
16,838 |
2008-07-16 |
62,513 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2008-02-20 |
90,369 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-11-03 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
16,606 |
2007-11-27 |
83,975 |
Premium* |
|
Glaukos Corp |
GKOS |
Director |
2015-06-24 |
5,000 |
2015-06-24 |
0 |
Premium* |
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
|
2019-02-22 |
255,942 |
|
0 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-30 |
46,683 |
2024-05-30 |
495,890 |
Premium* |
|
Allakos Inc. |
ALLK |
member - potential 10%... |
2021-03-05 |
0 |
2021-03-05 |
2,071,147 |
Premium* |
|
Tyra Biosciences, Inc. |
TYRA |
Director |
|
0 |
2021-09-17 |
4,080,296 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NUVA |
Nuvasive Inc |
10% Owner |
|
2004-05-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,000 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
|
2005-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
19,166 |
|
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2006-05-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,333 |
|
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2006-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
157,497 |
|
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2006-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,500 |
|
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2007-04-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
260,000 |
|
- |
|
SNNA |
Sienna Biopharmaceuticals... |
Director |
|
2017-07-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
34,071 |
|
- |
|
TYRA |
Tyra Biosciences, Inc. |
Director |
|
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
112,929 |
|
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2008-04-24 |
4 |
A |
$0.00 |
$0 |
I/I |
1,480 |
56,718 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-07-01 |
4 |
A |
$43.53 |
$72,739 |
D/D |
1,671 |
47,700 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2007-05-25 |
4/A |
A |
$0.00 |
$0 |
I/I |
1,862 |
1,862 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2007-11-27 |
4 |
A |
$0.00 |
$0 |
I/I |
1,963 |
1,963 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,374 |
92,709 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-06-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,374) |
39,061 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
3,374 |
489,485 |
0 |
- |
|
ALLK |
Allakos Inc. |
member - potential 10% group |
|
2021-03-03 |
4 |
S |
$110.89 |
$552,094 |
D/D |
(4,878) |
27,676 |
0 |
% |
|
GKOS |
Glaukos Corp |
Director |
|
2015-06-24 |
4 |
B |
$18.00 |
$90,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-09-13 |
4 |
A |
$0.00 |
$0 |
I/I |
5,842 |
5,842 |
|
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
45,088 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,405 |
42,435 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-10-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,405) |
38,683 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
6,405 |
495,890 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-09-18 |
4 |
S |
$13.03 |
$84,161 |
I/I |
(6,459) |
25,838 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-12-21 |
4 |
S |
$13.52 |
$87,326 |
I/I |
(6,459) |
19,379 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2024-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
46,683 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|